US HB8168 | 2019-2020 | 116th Congress

Status

Spectrum: Partisan Bill (Democrat 17-0)
Status: Introduced on September 4 2020 - 25% progression, died in committee
Action: 2020-09-04 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]

Summary

To require the guidance of the Food and Drug Administration on reducing the risk of human immunodeficiency virus (HIV), hepatitis A, and hepatitis B transmission by blood and blood products (including the donor history questionnaire) to be based on an individual risk assessment of sexual behaviors upon which all donors are evaluated equally, without regard to sexual orientation or gender identity, and for other purposes.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Science in Blood Donation Act of 2020

Sponsors


History

DateChamberAction
2020-09-04HouseReferred to the House Committee on Energy and Commerce.
2020-09-04HouseIntroduced in House

Subjects


US Congress State Sources


Bill Comments

feedback